Identifying Key Blind Spots in Your Diagnostic Strategy: Considerations for Defining Complex Biomarkers
Time: 8:50 am
day: Day 1 AM
Details:
- Explore key considerations for defining biomarkers as part of your CDx strategy
- Gain insights into the complexity of defining biomarkers like TMB, MSI, HRDSig, and CH
- Uncover potential blind spots in your CDx strategy and identify factors to consider in choosing a diagnostic partner